Alpha-gal syndrome

Chin Med J (Engl). 2024 Mar 26. doi: 10.1097/CM9.0000000000003063. Online ahead of print.

Mengyuan Zhan^{1

2

3}, Shaohui Chen^{4

5}, Tengda Xu^{4

5}, Jia Yin^{1

2

3}, Hao Li⁶, Zhouxian Pan^{1

2

3}, Ning Cui⁷, Liping Wen^{1

2

3}

¹ Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
² State Key Laboratory of Complex Severe and Rare Diseases, Beijing 100730, China.
³ National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China.
⁴ Department of Health Care, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
⁵ Department of Anesthesiology, Chinese Academy of Medical College and Peking Union Medical College Hospital, Beijing 100730, China.
⁶ State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing Key Laboratory of Vector Borne and Natural Focus Infectious Diseases, Beijing 100071, China.
⁷ The NO.154 Hospital, Xinyang, Henan 464000, China.

No abstract available